(Q36741644)

16 August 2017

Impact of multitiered copayments on the use and cost of prescription drugs among Medicare beneficiaries (English)

1 reference

16 August 2017

Boyd H Gilman

1

1 reference

PMCID

2442369

16 August 2017

John Kautter

series ordinal

2

1 reference

PMCID

2442369

16 August 2017

language of work or name

1 reference

1 April 2008

1 reference

16 August 2017

Health Services Research

1 reference

16 August 2017

43

1 reference

16 August 2017

2

1 reference

16 August 2017

478-495

1 reference

Consumer response to dual incentives under multitiered prescription drug formularies.

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

A copayment increase for prescription drugs: the long-term and short-term effects on use and expenditures

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

The effects of prescription drug cost sharing: a review of the evidence.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

Are incentive-based formularies inversely associated with drug utilization in managed care?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

Risk adjustment of Medicare capitation payments using the CMS-HCC model

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

Medicare drug coverage and moral hazard

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

The effect of incentive-based formularies on prescription-drug utilization and spending

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

Effects of a 3-tier pharmacy benefit design on the prescription purchasing behavior of individuals with chronic disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

Effect of tiered prescription copayments on the use of preferred brand medications

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

Effect of a three-tier prescription copay on pharmaceutical and other medical utilization

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

Effect of increased cost-sharing on oral hypoglycemic use in five managed care organizations: how much is too much?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

Three-tiered-copayment drug coverage and use of nonsteroidal anti-inflammatory drugs

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

Pharmacy benefits and the use of drugs by the chronically ill.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

Employer drug benefit plans and spending on prescription drugs

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

How do incentive-based formularies influence drug selection and spending for hypertension?

28 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1475-6773.2007.00774.X

Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1475-6773.2007.00774.X

The effects of prescription drug copayments on statin adherence

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

Impact of health plan design and management on retirees' prescription drug use and spending, 2001.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2442369

10.1111/J.1475-6773.2007.00774.X

5 September 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference

16 August 2017

1 reference

PMCID

2442369